Analyst Group: Analyst Group Comment on Eevia Health's Q4-Report
On February 14th, Eevia Health published the company’s quarterly report for Q4-23.
The following are some points that we have chosen to highlight from the report:
· The reported net sales fell short of our estimates
· Strong gross margin contributed to the first full year with positive EBITDA
· Recent positive development bodes well for future growth
· Short-term financial position secured by credit facility
Read Analyst Group’s comment on the report here
About Analyst Group: One of Sweden's leading equity analysis houses with a focus on small and medium-sized listed companies.
Read more about Analyst Group
This is a press release from Analyst Group regarding the publication of comments on Eevia Health. Readers may assume that Analyst Group has received compensation for making the commentary. The Company has not been given an opportunity to influence the parts where Analyst Group has had opinions about the Company, future valuation or anything else that could be considered a subjective assessment.